Global Pharmaceuticals & Biotech Big Green Snowflakes

Verona Pharma

Market Cap: US$9.2b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Intervacc

Market Cap: SEK 386.5m

Develops novel veterinary vaccines for animals in Sweden.

Stem Cells Spin

Market Cap: zł14.6m

Operates as a biotechnology company in Poland.

Exagen

Market Cap: US$215.6m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Whitehawk Therapeutics

Market Cap: US$84.8m

An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

Medigene

Market Cap: €908.1k

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

Nuvalent

Market Cap: US$5.7b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Cryoport

Market Cap: US$493.2m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

ProBiotix Health

Market Cap: UK£12.3m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Crinetics Pharmaceuticals

Market Cap: US$3.4b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Lisata Therapeutics

Market Cap: US$19.3m

A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.

Neurogene

Market Cap: US$274.7m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Solvonis Therapeutics

Market Cap: UK£17.9m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

Sareum Holdings

Market Cap: UK£34.0m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Alumis

Market Cap: US$444.4m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Delivra Health Brands

Market Cap: CA$5.9m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Natera

Market Cap: US$23.3b

A diagnostics company, provides molecular testing services worldwide.

Phio Pharmaceuticals

Market Cap: US$14.0m

A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

Handa Pharmaceuticals

Market Cap: NT$16.8b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

Welgene BiotechLtd

Market Cap: NT$510.4m

Provides genetic testing services.

CSPC Innovation Pharmaceutical

Market Cap: CN¥78.0b

Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.

Aurisco PharmaceuticalLtd

Market Cap: CN¥9.4b

Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide.

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥30.3b

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Immuron

Market Cap: AU$18.5m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Newland Pharmaceutical

Market Cap: CN¥5.3b

Engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China.

Island Pharmaceuticals

Market Cap: AU$70.6m

A drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America.

Bafna Pharmaceuticals

Market Cap: ₹2.5b

Manufactures and sells finished pharmaceutical formulations in India.

Source Natural Foods and Herbal Supplements

Market Cap: ₹916.3m

Manufactures and sells ayurveda, health and dietary supplements, and food products in India.

Nectar Lifesciences

Market Cap: ₹3.4b

Manufactures, distributes, markets and sells pharmaceutical products in India and internationally.

Paradigm Biopharmaceuticals

Market Cap: AU$105.3m

Engages in the research and development of therapeutic products for human use in Australia.

Walvax Biotechnology

Market Cap: CN¥19.9b

Engages in the research and development, manufacture, and distribution of vaccines in China.

Bicara Therapeutics

Market Cap: US$679.9m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Genfit

Market Cap: €176.2m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Liquidia

Market Cap: US$2.4b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Sana Biotechnology

Market Cap: US$791.4m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Jasper Therapeutics

Market Cap: US$42.1m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.